These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 14693747

  • 21. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.
    Rusiecki JA, Holford TR, Zahm SH, Zheng T.
    Cancer Detect Prev; 2005; 29(5):419-26. PubMed ID: 16185815
    [Abstract] [Full Text] [Related]

  • 22. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Chu KC, Chang S, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
    [Abstract] [Full Text] [Related]

  • 23. Urbanization and breast cancer incidence in North Carolina, 1995-1999.
    Hall SA, Kaufman JS, Millikan RC, Ricketts TC, Herman D, Savitz DA.
    Ann Epidemiol; 2005 Nov; 15(10):796-803. PubMed ID: 15922628
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 25. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators.
    J Natl Cancer Inst; 2007 Nov 21; 99(22):1695-705. PubMed ID: 18000216
    [Abstract] [Full Text] [Related]

  • 26. Ethnicity and breast cancer in Hawaii: increased survival but continued disparity.
    Braun KL, Fong M, Gotay C, Pagano IS, Chong C.
    Ethn Dis; 2005 Nov 21; 15(3):453-60. PubMed ID: 16108306
    [Abstract] [Full Text] [Related]

  • 27. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar 21; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

  • 28. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI.
    Cancer; 2005 Jun 01; 103(11):2241-51. PubMed ID: 15844176
    [Abstract] [Full Text] [Related]

  • 29. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R.
    Cancer; 2006 Aug 15; 107(4):696-704. PubMed ID: 16826579
    [Abstract] [Full Text] [Related]

  • 30. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
    Chakrabarti I, Cockburn M, Cozen W, Wang YP, Preston-Martin S.
    Cancer; 2005 Dec 15; 104(12):2798-806. PubMed ID: 16288487
    [Abstract] [Full Text] [Related]

  • 31. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Pfeiffer RM, Dores GM, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 15; 15(10):1899-905. PubMed ID: 17035397
    [Abstract] [Full Text] [Related]

  • 32. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
    Anderson WF, Jatoi I, Devesa SS.
    Breast Cancer Res Treat; 2005 Mar 15; 90(2):127-37. PubMed ID: 15803359
    [Abstract] [Full Text] [Related]

  • 33. Obesity and risk of the less commonly diagnosed subtypes of breast cancer.
    Stark A, Schultz D, Kapke A, Nadkarni P, Burke M, Linden M, Raju U.
    Eur J Surg Oncol; 2009 Sep 15; 35(9):928-35. PubMed ID: 19121564
    [Abstract] [Full Text] [Related]

  • 34. Race/ethnicity and changing US socioeconomic gradients in breast cancer incidence: California and Massachusetts, 1978-2002 (United States).
    Krieger N, Chen JT, Waterman PD, Rehkopf DH, Yin R, Coull BA.
    Cancer Causes Control; 2006 Mar 15; 17(2):217-26. PubMed ID: 16425100
    [Abstract] [Full Text] [Related]

  • 35. Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study.
    Dalessandri KM, Miike R, Wiencke JK, Farren G, Pugh TW, Manjeshwar S, DeFreese DC, Jupe ER.
    J Am Coll Surg; 2012 Nov 15; 215(5):652-7. PubMed ID: 22867716
    [Abstract] [Full Text] [Related]

  • 36. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.
    Cancer; 2004 Oct 01; 101(7):1490-500. PubMed ID: 15378477
    [Abstract] [Full Text] [Related]

  • 37. Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer.
    Lumachi F, Ermani M, Marino F, Di Cristofaro L, Tombolan V, Brunello A, Roma A, Basso U.
    Anticancer Res; 2008 Oct 01; 28(1B):491-3. PubMed ID: 18383890
    [Abstract] [Full Text] [Related]

  • 38. Alcohol consumption and breast cancer risk in the Women's Health Study.
    Zhang SM, Lee IM, Manson JE, Cook NR, Willett WC, Buring JE.
    Am J Epidemiol; 2007 Mar 15; 165(6):667-76. PubMed ID: 17204515
    [Abstract] [Full Text] [Related]

  • 39. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 40. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):121-31. PubMed ID: 19124489
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.